Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Rosselló X[Au]:

Predicting 30-Day Mortality for Patients With Acute Heart Failure in the Emergency Department: A Cohort Study. Miró Ò et al. Ann Intern Med. (2017)

The RISK pathway and beyond. Rossello X et al. Basic Res Cardiol. (2018)

The role of PI3Kα isoform in cardioprotection. Rossello X et al. Basic Res Cardiol. (2017)

Search results

Items: 1 to 20 of 42

1.

Digital learning and the future cardiologist.

Rosselló X, Stanbury M, Beeri R, Kirchhof P, Casadei B, Kotecha D.

Eur Heart J. 2019 Feb 7;40(6):499-501. doi: 10.1093/eurheartj/ehy884. No abstract available.

PMID:
30698713
2.

External Validation of the MEESSI Acute Heart Failure Risk Score: A Cohort Study.

Wussler D, Kozhuharov N, Sabti Z, Walter J, Strebel I, Scholl L, Miró O, Rossello X, Martín-Sánchez FJ, Pocock SJ, Nowak A, Badertscher P, Twerenbold R, Wildi K, Puelacher C, du Fay de Lavallaz J, Shrestha S, Strauch O, Flores D, Nestelberger T, Boeddinghaus J, Schumacher C, Goudev A, Pfister O, Breidthardt T, Mueller C.

Ann Intern Med. 2019 Jan 29. doi: 10.7326/M18-1967. [Epub ahead of print]

PMID:
30690646
3.

Effect of Barthel Index on the Risk of Thirty-Day Mortality in Patients With Acute Heart Failure Attending the Emergency Department: A Cohort Study of Nine Thousand Ninety-Eight Patients From the Epidemiology of Acute Heart Failure in Emergency Departments Registry.

Rossello X, Miró Ò, Llorens P, Jacob J, Herrero-Puente P, Gil V, Rizzi MA, Pérez-Durá MJ, Espiga FR, Romero R, Sevillano JA, Vidán MT, Bueno H, Pocock SJ, Martín-Sánchez FJ; ICA-SEMES Research Group.

Ann Emerg Med. 2019 Jan 23. pii: S0196-0644(18)31558-0. doi: 10.1016/j.annemergmed.2018.12.009. [Epub ahead of print]

PMID:
30685211
4.

Planning to reduce 30-day adverse events after discharge of frail elderly patients with acute heart failure: design and rationale for the DEED FRAIL-AHF trial.

Martín-Sánchez FJ, Llopis García G, Llorens P, Jacob J, Herrero P, Gil V, Pastor AJ, López-Picado A, Fuentes Ferrer M, Rosselló X, Gil P, Díez Villanueva P, Calvo E, Méndez Bailón M, Cuesta-Triana F, González Armengol JJ, González Del Castillo J, Runtkle I, Vidán MT, Comín-Colet J, Cruz Jentoft A, Bueno H, Miró Ò, Fernández Pérez C.

Emergencias. 2019 Ene;31(1):27-35. English, Spanish.

PMID:
30656870
5.

Patients with acute heart failure discharged from the emergency department and classified as low risk by the MEESSI score (multiple risk estimate based on the Spanish emergency department scale): prevalence of adverse events and predictability.

Miró Ò, Gil V, Rosselló X, Martín-Sánchez FJ, Llorens P, Jacob J, Herrero P, Herrera Mateo S, Richard F, Escoda R, Fuentes M, Martín Mojarro E, Llauger L, Bueno H, Pocock S.

Emergencias. 2019 Ene;31(1):5-14. English, Spanish.

PMID:
30656867
6.

Predictors of all-cause mortality and ischemic events within and beyond 1 year after an acute coronary syndrome: Results from the EPICOR registry.

Rossello X, Bueno H, Pocock SJ, Van de Werf F, Danchin N, Annemans L, Medina J, Zeymer U.

Clin Cardiol. 2019 Jan;42(1):111-119. doi: 10.1002/clc.23116. Epub 2018 Dec 7.

7.

Prognostic value of a new semiquantitative score system for adenosine stress myocardial perfusion by CMR.

Gómez-Revelles S, Rossello X, Díaz-Villanueva J, López-Lima I, Sciarresi E, Estofán M, Carreras F, Pujadas S, Pons-Lladó G.

Eur Radiol. 2018 Nov 7. doi: 10.1007/s00330-018-5774-7. [Epub ahead of print]

PMID:
30406310
8.

Impact of mineralocorticoid receptor antagonists on the risk of sudden cardiac death in patients with heart failure and left-ventricular systolic dysfunction: an individual patient-level meta-analysis of three randomized-controlled trials.

Rossello X, Ariti C, Pocock SJ, Ferreira JP, Girerd N, McMurray JJV, Van Veldhuisen DJ, Pitt B, Zannad F.

Clin Res Cardiol. 2018 Sep 27. doi: 10.1007/s00392-018-1378-0. [Epub ahead of print]

PMID:
30264282
9.

Impact of insulin-treated diabetes on cardiovascular outcomes following high-risk myocardial infarction.

Rossello X, Ferreira JP, McMurray JJ, Aguilar D, Pfeffer MA, Pitt B, Dickstein K, Girerd N, Rossignol P, Zannad F; High-Risk Myocardial Infarction Database Initiative.

Eur Heart J Acute Cardiovasc Care. 2018 Sep 27:2048872618803701. doi: 10.1177/2048872618803701. [Epub ahead of print]

PMID:
30259764
10.

Identification of Senior At Risk scale predicts 30-day mortality among older patients with acute heart failure.

Martín-Sánchez FJ, Llopis García G, González-Colaço Harmand M, Fernandez Pérez C, González Del Castillo J, Llorens P, Herrero P, Jacob J, Gil V, Domínguez-Rodriguez A, Rossello X, Miró O; en representación de los investigadores del Registro OAK; Resto de investigadores del registro OAK.

Med Intensiva. 2018 Aug 27. pii: S0210-5691(18)30218-3. doi: 10.1016/j.medin.2018.07.009. [Epub ahead of print] English, Spanish.

PMID:
30166245
11.

Mirabegron, a Clinically Approved β3 Adrenergic Receptor Agonist, Does Not Reduce Infarct Size in a Swine Model of Reperfused Myocardial Infarction.

Rossello X, Piñero A, Fernández-Jiménez R, Sánchez-González J, Pizarro G, Galán-Arriola C, Lobo-Gonzalez M, Vilchez JP, García-Prieto J, García-Ruiz JM, García-Álvarez A, Sanz-Rosa D, Ibanez B.

J Cardiovasc Transl Res. 2018 Aug;11(4):310-318. doi: 10.1007/s12265-018-9819-8. Epub 2018 Aug 2.

PMID:
30073540
12.

Apoptosis, A Double-Edge Sword!

Rossello X, Yellon DM.

JACC Basic Transl Sci. 2017 Aug 28;2(4):498. doi: 10.1016/j.jacbts.2017.07.008. eCollection 2017 Aug. No abstract available.

13.

The Usefulness of the MEESSI Score for Risk Stratification of Patients With Acute Heart Failure at the Emergency Department.

Miró Ò, Rosselló X, Gil V, Martín-Sánchez FJ, Llorens P, Herrero P, Jacob J, López-Grima ML, Gil C, Lucas Imbernón FJ, Garrido JM, Pérez-Durá MJ, López-Díez MP, Richard F, Bueno H, Pocock SJ.

Rev Esp Cardiol (Engl Ed). 2019 Mar;72(3):198-207. doi: 10.1016/j.rec.2018.05.002. Epub 2018 Jun 11. English, Spanish.

PMID:
29903688
14.

Regional variations in hospital management and post-discharge mortality in patients with non-ST-segment elevation acute coronary syndrome.

Bueno H, Rossello X, Pocock S, Van de Werf F, Chin CT, Danchin N, Lee SW, Medina J, Vega A, Huo Y.

Clin Res Cardiol. 2018 Sep;107(9):836-844. doi: 10.1007/s00392-018-1254-y. Epub 2018 Apr 16.

PMID:
29663124
15.

Myocardial Infarct Size Reduction Provided by Local and Remote Ischaemic Preconditioning: References Values from the Hatter Cardiovascular Institute.

Rossello X, He Z, Yellon DM.

Cardiovasc Drugs Ther. 2018 Apr;32(2):127-133. doi: 10.1007/s10557-018-6788-8.

16.

Infarct Size Reduction by Targeting Ischemic Injury: Back to Square One.

Rossello X, Ibanez B.

Circ Res. 2018 Apr 13;122(8):1041-1043. doi: 10.1161/CIRCRESAHA.118.312939. No abstract available.

PMID:
29650626
17.

Xenon: A Noble Member of the Cardioprotection Club.

Yellon DM, Rossello X.

J Am Coll Cardiol. 2017 Nov 28;70(21):2661-2662. doi: 10.1016/j.jacc.2017.10.004. No abstract available.

18.

Role of PI3K in myocardial ischaemic preconditioning: mapping pro-survival cascades at the trigger phase and at reperfusion.

Rossello X, Riquelme JA, Davidson SM, Yellon DM.

J Cell Mol Med. 2018 Feb;22(2):926-935. doi: 10.1111/jcmm.13394. Epub 2017 Nov 20.

19.

The RISK pathway and beyond.

Rossello X, Yellon DM.

Basic Res Cardiol. 2017 Nov 15;113(1):2. doi: 10.1007/s00395-017-0662-x. Print 2018 Jan 8. Review.

20.

The role of PI3Kα isoform in cardioprotection.

Rossello X, Riquelme JA, He Z, Taferner S, Vanhaesebroeck B, Davidson SM, Yellon DM.

Basic Res Cardiol. 2017 Oct 17;112(6):66. doi: 10.1007/s00395-017-0657-7.

Supplemental Content

Loading ...
Support Center